Press Room

Pharmaceutical Continuous Manufacturing (PCM) Business Summit

Start
Wednesday, September 27, 2023
End
Wednesday, September 27, 2023
Location: New Jersey, USA

HOVIONE PRESENTATION AT Pharmaceutical Continuous Manufacturing (PCM) Business Summit.

In New Jersey, Sarang Oka – Production Senior Manager, Drug Product Continuous Manufacturing, is hosting a presentation entitled “A short journey in Commercial Manufacturing with PCM” from 3:30 – 4:00 pm.

In this presentation, Sarang will provide a brief glimpse related to the implementation of pharmaceutical continuous manufacturing (tableting) at Hovione, NJ. He will also discuss some learnings from implementation of continuous tableting in a commercial environment. Case studies will focus on the use of big data sets to assess process health, and how these data sets lend themselves to implement simple analysis tools as SPC.  

 

schedule a meeting

 

 

 

Get to know more on Continuous Tableting 

 

More on the Congress

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025